Lecithin is not effective in amyotrophic lateral sclerosis

Abstract
Eleven patients with motor neuron disease (9 with amyotrophic lateral sclerosis, one with spinal muscular atrophy, and one with postpolio motor neuron disease) were treated with lecithin (55% phosphatidylcholine, 20 gm per day) for 3 to 12½ months. Response was measured by quantitated muscle testing and functional evaluations of patients and untreated, matched controls. Lecithin therapy did not provide therapeutic benefit.